Cranbrook Wealth Management’s Hologic HOLX Stock Holding History

Cranbrook Wealth Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,851	Closed	-$367K	–	410
2026 Q1	$367K	Hold	4,851	–	–	0.07%	99
2025 Q4	$361K	Buy	4,851 +1,083	+29%	+$79.1K	0.07%	99
2025 Q3	$254K	Hold	3,768	–	–	0.05%	112
2025 Q2	$246K	Hold	3,768	–	–	0.05%	108
2025 Q1	$233K	Hold	3,768	–	–	0.05%	101
2024 Q4	$272K	Sell	3,768 -234	-6%	-$18.3K	0.06%	100
2024 Q3	$326K	Buy	4,002 +3,375	+538%	+$270K	0.07%	93
2024 Q2	$46.6K	Buy	+627	New	+$47K	0.01%	184

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cranbrook Wealth Management's HOLX Position: Q2 2026 in Review

Cranbrook Wealth Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 4,851 shares — an estimated $367K sold.

Cranbrook Wealth Management first reported a position in HOLX in Q2 2024 and held it in 8 quarters. The position peaked at $367K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Cranbrook Wealth Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Cranbrook Wealth Management sold 4,851 Hologic shares in Q2 2026, an estimated $367K.
Cranbrook Wealth Management first reported a position in Hologic in Q2 2024 and held it in 8 quarters.
Cranbrook Wealth Management's Hologic position peaked at $367K in Q1 2026.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.